Immunomodulators for treatment of interstitial cystitis

Urology

Volumn 65, Issue 4, 2005, Pages 633-638

  Theoharides, Theoharis C ^a   Sant, Grannum R ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; CYSTAQ; CYSTOPROTEK; EMBREL; ETANERCEPT; FOLINIC ACID; GELATIN; HYALURONIC ACID; IMATINIB; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; MICROSPHERE; MONTELUKAST; PROPRANOLOL; QUERCETIN; RECOMBINANT INTERLEUKIN 10; SUPLATAST TOSYLATE; THEOPHYLLINE; UNCLASSIFIED DRUG; ZAFIRLUKAST; ZILEUTON;

BONE MARROW SUPPRESSION; CELL INTERACTION; CHEILITIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFECT; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; HEADACHE; HUMAN; INFECTION SENSITIVITY; INTERSTITIAL CYSTITIS; LOW DRUG DOSE; LUNG INFECTION; MAST CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 17144402982     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.08.052     Document Type: Review

References (54)

1. C.L. Parsons, D. Boychuk, S. Jones Bladder surface glycosaminoglycans an epithelial permeability barrier J Urol 143 1990 139 142
2. T.C. Theoharides, D. Kempuraj, G.R. Sant Mast cell involvement in interstitial cystitis a review of human and experimental evidence Urology 57 suppl 6A 2001 47 55
3. T.C. Theoharides, G.R. Sant Neuroimmune connections and regulation of function in the urinary bladder J. Bienenstock E. Goetzl M. Blennerhassett Autonomic Neuroimmunology vol 15 2003 Hardwood Academic Lausanne, Switzerland 345 369
4. G.R. Sant, P.M. Hanno Interstitial cystitis current issues and controversies in diagnosis Urology 57 2001 82 88
5. J.A. Koziol, D.C. Clark, R.F. Gittes The natural history of interstitial cystitis a survey of 374 patients J Urol 149 1993 465 469
6. N.E. Rothrock, S.K. Lutgendorf, K.J. Kreder Stress and symptoms in patients with interstitial cystitis a life stress model Urology 57 2001 422 427
7. T.C. Theoharides, D.E. Cochrane Critical role of mast cells in inflammatory diseases and the effect of acute stress J Neuroimmunol 146 2004 1 12
8. T.C. Theoharides Panic disorder, interstitial cystitis and mast cells J Clin Psychopharmacol 24 2004 361 364
9. T.C. Theoharides, G.R. Sant New agents for the medical treatment of interstitial cystitis Exp Opin Invest Drugs 10 2001 521 546
10. G.R. Sant, K.J. Propert, P.M. Hanno A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis J Urol 170 2003 810 815
11. T.C. Theoharides, X. Pang, R. Letourneau Interstitial cystitis a neuroimmunoendocrine disorder Ann NY Acad Sci 840 1998 619 634
12. M. Fall, F. Aldenborg, S. Johansson Clinical characteristics support that interstitial cystitis is a heterogeneous syndrome Urology 57 2001 129 130
13. Lane BR, Rackley RR, Abdelmalak JB,, et al. Presented at the NIH/ICA Meeting, October 30 to November 1, 2003, p 65. Available at: http://www.ichelp.com/research/2003AUAAnnualMeetingAbstracts.html. Accessed August 11, 2004.
14. Seikagaku Corporation, Japan: Novel therapy for IC not found to be effective, 2004; 3-11-2004. Available at: http://www.ichelp.com/research/ NovelTherapyNotEffective.html. Accessed August 12, 2004.
15. D.R. Erickson, D.A. Belchis, D.J. Dabbs Inflammatory cell types and clinical features of interstitial cystitis J Urol 158 1997 790 793
16. J.E. Tomaszewski, J.R. Landis, V. Russack Biopsy features are associated with primary symptoms in interstitial cystitis results from the Interstitial Cystitis Database study Urology 57 suppl 6A 2001 67 81
17. R. Malaviya, T. Ikeda, E. Ross Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α Nature 381 1996 77 80
18. M. Green, A. Filippou, G. Sant Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis Urology 63 2004 1 6
19. D. Felsen, S. Frye, L.A. Trimble Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis Urology 152 1994 355 361
20. K. Kandere-Grzybowska, R. Letourneau, W. Boucher IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells J Immunol 171 2003 4830 4836
21. M. Huang, X. Pang, K. Karalis Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice Cardiovasc Res 59 2003 241 249
22. X. Pang, W. Boucher, G. Triadafilopoulos Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis Urology 47 1996 436 438
23. N. Alexacos, X. Pang, W. Boucher Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress Urology 53 1999 1035 1040
24. D. Kempuraj, N.G. Papadopoulou, M. Lytinas Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells Endocrinology 145 2004 43 48
25. C. Stellato, A. de Paulis, A. Ciccarelli Anti-inflammatory effect of cyclosporin A on human skin mast cells J Invest Dermatol 98 1992 800 804
26. T. Forsell, M. Ruutu, H. Isoniemi Cyclosporine in severe interstitial cystitis J Urol 155 1996 1591 1593
27. D.A. Fox Cytokine blockade as a new strategy to treat rheumatoid arthritis inhibition of tumor necrosis factor Arch Intern Med 160 2000 437 444
28. K. Asadullah, W. Sterry, H.D. Volk Interleukin-10 therapy--review of a new approach Pharmacol Rev 55 2003 241 269
29. T.J. Lin, A.D. Befus Differential regulation of mast cell function by IL-10 and stem cell factor J Immunol 159 1997 4015 4023
30. P. Conti, D. Kempuraj, K. Kandere IL-10, an inflammatory/inhibitory cytokine, but not always Immunol Lett 86 2003 123 129
31. M.C. Li, S.H. He IL-10 and its related cytokines for treatment of inflammatory bowel disease World J Gastroenterol 10 2004 620 625
32. X. Pang, G.R. Sant, T.C. Theoharides Altered expression of bladder mast cell growth factor receptor (c-kit) expression in interstitial cystitis Urology 51 1998 939 944
33. G. Nilsson, J.H. Butterfield, K. Nilsson Stem cell factor is a chemotactic factor for human mast cells J Immunol 153 1994 3717 3723
34. A. de Paulis, G. Minopoli, E. Arbustini Stem cell factor is localized in, released from, and cleaved by human mast cells J Immunol 163 1999 2799 2808
35. B.J. Longley Jr, G.S. Morganroth, L. Tyrrell Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis N Engl J Med 328 1993 1302 1307
36. D.M. Ross, T.P. Hughes Cancer treatment with kinase inhibitors what have we learnt from imatinib? Br J Cancer 90 2004 12 19
37. A. Pardanani, M. Elliott, T. Reeder Imatinib for systemic mast-cell disease Lancet 362 2003 535 536
38. H. Ogata, T. Hibi Cytokine and anti-cytokine therapies for inflammatory bowel disease Curr Pharm Des 9 2003 1107 1113
39. P.A. Moran, P.L. Dwyer, M.P. Carey Oral methotrexate in the management of refractory interstitial cystitis Aust NZ J Obstet Gynaecol 39 1999 468 471
40. T.F. Reiss, P. Chervinsky, R.J. Dockhorn Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma Arch Intern Med 158 1998 1213 1220
41. K. Bouchelouche, J. Nordling, T. Hald The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis J Urol 166 2001 1734 1737
42. K. Furukido, S. Takeno, T. Ueda Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies Am J Rhinol 16 2002 329 336
43. T. Ueda, M. Tamaki, O. Ogawa Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T J Urol 164 2000 1917 1920
44. M.G. Alexandrakis, R. Letourneau, D. Kempuraj Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1) Eur J Haematol 71 2003 448 454
45. E. Middleton Jr, C. Kandaswami, T.C. Theoharides The effects of plant flavonoids on mammalian cells implications for inflammation, heart disease and cancer Pharmacol Rev 52 2000 673 751
46. F.L. Pearce, A.D. Befus, J. Bienenstock Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells J Allergy Clin Immunol 73 1984 819 823
47. F. Katske, D.A. Shoskes, M. Sender Treatment of interstitial cystitis with a quercetin supplement Tech Urol 7 2001 44 46
48. T.C. Theoharides, L. Bielory Mast cells and mast cell mediators as targets of dietary supplements Ann Allergy Asthma Immunol 92 2004 1 11
49. T.C. Theoharides Dietary supplements for arthritis and other inflammatory conditions key role of mast cells and benefit of combining anti-inflammatory and proteoglycan products Eur J Inflamm 1 2003 1 8
50. W. Boucher, R. Letourneau, M. Huang Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress J Urol 167 2002 380 384
51. T.C. Theoharides, P. Patra, W. Boucher Chondroitin sulfate inhibits connective tissue mast cells Br J Pharmacol 131 2000 1039 1049
52. T.C. Theoharides, G.R. Sant A pilot, open label, clinical study of CystoProtek® in interstitial cystitis patients Int J Immunopathol Pharmacol 18 2005 183 188
53. D.K. Grammatopoulos, G.P. Chrousos Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists Trends Endocrinol Metab 13 2002 436 444
54. T.C. Theoharides, J.M. Donelan, N. Papadopoulou Mast cells as targets of corticotropin-releasing factor and related peptides Trends Pharmacol Sci 25 2004 563 568